Literature DB >> 20658986

From tau phosphorylation to tau aggregation: what about neuronal death?

Luc Buée1, Laëtitia Troquier, Sylvie Burnouf, Karim Belarbi, Anneke Van der Jeugd, Tariq Ahmed, Francisco Fernandez-Gomez, Raphaelle Caillierez, Marie-Eve Grosjean, Séverine Begard, Bérangère Barbot, Dominique Demeyer, Hélène Obriot, Ingrid Brion, Valérie Buée-Scherrer, Claude-Alain Maurage, Detlef Balschun, Rudi D'hooge, Malika Hamdane, David Blum, Nicolas Sergeant.   

Abstract

Tau pathology is characterized by intracellular aggregates of abnormally and hyperphosphorylated tau proteins. It is encountered in many neurodegenerative disorders, but also in aging. These neurodegenerative disorders are referred to as tauopathies. Comparative biochemistry of the tau aggregates shows that they differ in both tau isoform phosphorylation and content, which enables a molecular classification of tauopathies. In conditions of dementia, NFD (neurofibrillary degeneration) severity is correlated to cognitive impairment and is often considered as neuronal death. Using tau animal models, analysis of the kinetics of tau phosphorylation, aggregation and neuronal death in parallel to electrophysiological and behavioural parameters indicates a disconnection between cognition deficits and neuronal cell death. Tau phosphorylation and aggregation are early events followed by cognitive impairment. Neuronal death is not observed before the oldest ages. A sequence of events may be the formation of toxic phosphorylated tau species, their aggregation, the formation of neurofibrillary tangles (from pre-tangles to ghost tangles) and finally neuronal cell death. This sequence will last from 15 to 25 years and one can ask whether the aggregation of toxic phosphorylated tau species is a protection against cell death. Apoptosis takes 24 h, but NFD lasts for 24 years to finally kill the neuron or rather to protect it for more than 20 years. Altogether, these data suggest that NFD is a transient state before neuronal death and that therapeutic interventions are possible at that stage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658986     DOI: 10.1042/BST0380967

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  35 in total

1.  Neurodegeneration: Recall sugars, forget Alzheimer's.

Authors:  Tony Lefebvre
Journal:  Nat Chem Biol       Date:  2012-03-16       Impact factor: 15.040

2.  MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.

Authors:  Saif Zaman; Boris I Chobrutskiy; George Blanck
Journal:  Cell Cycle       Date:  2018-11-18       Impact factor: 4.534

3.  Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10.

Authors:  Maria Tsachaki; Despina Serlidaki; Andriana Fetani; Vasiliki Zarkou; Ismini Rozani; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  Glycobiology       Date:  2011-07-13       Impact factor: 4.313

4.  Late-onset Alzheimer's disease, heating up and foxed by several proteins: pathomolecular effects of the aging process.

Authors:  Felipe P Perez; David Bose; Bryan Maloney; Kwangsik Nho; Kavita Shah; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity.

Authors:  Allyson V McCormick; Jeanna M Wheeler; Chris R Guthrie; Nicole F Liachko; Brian C Kraemer
Journal:  Biol Psychiatry       Date:  2012-11-07       Impact factor: 13.382

6.  Aggravation effect of isoflurane on Aβ(25-35)-induced apoptosis and tau hyperphosphorylation in PC12 cells.

Authors:  Jie Xu; Rui Zhang; Pingping Zuo; Nan Yang; Chao Ji; Weiran Liu; Yun Wang; Hui Wang; Anshi Wu; Yun Yue; Yanyong Liu
Journal:  Cell Mol Neurobiol       Date:  2012-07-20       Impact factor: 5.046

7.  Microtubule affinity regulating kinase activity in living neurons was examined by a genetically encoded fluorescence resonance energy transfer/fluorescence lifetime imaging-based biosensor: inhibitors with therapeutic potential.

Authors:  Thomas Timm; Jens Peter von Kries; Xiaoyu Li; Hans Zempel; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

8.  Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice.

Authors:  Guorong Tao; Jie Zhang; Lei Zhang; Yuanlin Dong; Buwei Yu; Gregory Crosby; Deborah J Culley; Yiying Zhang; Zhongcong Xie
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

Review 9.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 10.  Dementia Risk in Posttraumatic Stress Disorder: the Relevance of Sleep-Related Abnormalities in Brain Structure, Amyloid, and Inflammation.

Authors:  Brian S Mohlenhoff; Aoife O'Donovan; Michael W Weiner; Thomas C Neylan
Journal:  Curr Psychiatry Rep       Date:  2017-10-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.